2018/09/11 by Yinghuai Zhu, Zhu Yinghuai, Xinglong Lin +5
Medicine · Materials Science · #Boron Compounds in Chemistry #Radiopharmaceutical Chemistry and Applications #Boron and Carbon Nanomaterials Research
paper · doi:10.2174/0929867325666180904105212
Boron-containing compounds are essential micronutrients for animals and plants despite their low-level natural occurrence. They can strengthen the cell walls of the plants and they play important role in supporting bone health. However, surprisingly, boron-containing compounds are seldom found in pharmaceutical drugs. In fact, there are no inherent disadvantages reported so far in terms of the incorporation of boron into medicines. Indeed, drugs based on boron-containing compounds, such as tavaborole (marked name Kerydin) and bortezomib (trade name Velcade) have been investigated and they are used in clinical treatment. In addition, following the advanced development of boron neutron capture therapy and a new emerging proton boron fusion therapy, more boron-containing medicinals are to be expected. This review discusses the current status and perspectives of delivery strategy for boron-containing drugs.